search
Company Information
USD
25.61
- (1.6%)
NASDAQ:PTGX, PROTAGONIST THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 19 April 2024 GMT-4
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Address

7707 Gateway Boulevard
Suite 140

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Daniel N. Swisher,Jr
Director
Dr. Harold E. Selick, PhD
Director/Chairman of the Board
Dr. Lewis T. Williams, M.D.,PhD
Director
Mr. William D. Waddill
Director
Dr. Dinesh V. Patel, PhD
CEO/Director/President
Mr. Bryan Giraudo
Director
Ms. Sarah A. O’Dowd
Director
Mr. Asif Ali
CFO/Chief Accounting Officer/Executive VP
Dr. Arturo Molina, M.D.
Chief Medical Officer
Mr. Suneel Gupta
Other Executive Officer

Ownership

Institution Holdings

Bvf Inc
5,744,848 (9.858%)
Farallon Capital Management, L.L.C.
5,734,430 (9.840%)
BlackRock Inc
5,543,902 (9.513%)
RTW INVESTMENTS, LLC
5,315,514 (9.121%)
BVF Partners LP
3,775,900 (6.547%)
Vanguard Group Inc
3,153,916 (5.412%)
State Street Corporation
2,729,929 (4.685%)
Johnson & Johnson
2,449,183 (4.203%)
BlackRock Fund Advisors
2,447,299 (4.200%)
Kynam Capital Management, LP
2,004,875 (3.440%)

Individual Holdings

Dr. Dinesh V. Patel, PhD
574,590 (0.986%)
Mr. Suneel Gupta
183,285 (0.315%)
Mr. Asif Ali
38,397 (0.066%)
Dr. Harold E. Selick, PhD
21,506 (0.038%)
Mr. Bryan Giraudo
10,000 (0.037%)
Mr. William D. Waddill
12,000 (0.021%)

Funds Holdings

SPDR® S&P Biotech ETF
1,575,518 (2.704%)
iShares Russell 2000 ETF
1,392,167 (2.389%)
Vanguard Institutional Extnd Mkt Idx Tr
843,074 (1.447%)
Fidelity Small Cap Index Fund
568,831 (0.976%)
iShares Biotechnology ETF
413,440 (0.709%)
State Street Russell Small/Mid Cap®
343,093 (0.589%)
Fidelity Extended Market Index Fund
321,408 (0.552%)
iShares Russell 2000 Growth ETF
315,239 (0.541%)
State Street Russell Small Cap® Index
210,680 (0.362%)
iShares Russell 2000 Value ETF
197,721 (0.339%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices